Amphastar’s Generic Ganirelix Acetate Injection Scores FDA Approval
The FDA has approved Amphastar Pharmaceuticals Inc’s (NASDAQ:AMPH) Abbreviated New Drug Application for Ganirelix Acetate Injection, 250mg/0.5mL in a prefilled syringe. …
Morgan Stanley Maintains Equal-Weight on Organon, Lowers Price Target to $35
Morgan Stanley analyst Terence Flynn maintains Organon (NYSE:OGN) with a Equal-Weight and lowers the price target from $37 to $35.
Organon Inks Licensing Pact For Daré Bioscience’s Bacterial Vaginosis Treatment
Organon & Co (NYSE: OGN)
Ethereum Whales Are Trading This NFT Coin The Most Today — And It’s Up 42%
Origin Protocol (CRYPTO: OGN) has emerged as the most traded cryptocurrency by the 1,000 biggest Ethereum (CRYPTO: ETH) wallets in the past 24 hours.
Morgan Stanley Maintains Equal-Weight on Organon, Raises Price Target to $37
Morgan Stanley maintains Organon (NYSE:OGN) with a Equal-Weight and raises the price target from $35 to $37.
Established Brands Hit Organon’s Q4 Sales, Expects FY22 Sales Of Upto $6.4B
Organon & Co's (NYSE: OGN)
Earnings Scheduled For February 17, 2022
Companies Reporting Before The Bell
• Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million.
Paris Hilton Invests In NFT Platform Origin Protocol, Launches More NFTs
American media personality, socialite and businesswoman Paris Hilton decided to jump on the non-fungible token bandwagon by investing in NFT platform Origin Protocol.